Stop Clopez Corp

Stop Clopez Corp's Schwinnng Recall: FDA Flags Unapproved Drug Masquerading as Herbal Supplement

Stop Clopez Corp initiated a Class I recall for its Schwinnng Herbal Dietary Supplement Capsules, distributed worldwide via amazon.com, due to marketing without FDA drug approval. This event highlights critical regulatory non-compliance, as the product was deemed an unapproved new drug. Procurement and regulatory teams must scrutinize suppliers of 'dietary supplements' for undeclared drug components or unapproved drug claims, mitigating significant market access and reputational risks.